IDBS

IDBS is an enterprise software-as-a-service (SaaS) and consulting company with over 35 years of experience delivering laboratory informatics solutions across the biopharmaceutical lifecycle — from R&D through manufacturing. The company's mission is to help customers improve patient lives by unlocking the power of data for faster and smarter decisions. IDBS serves a broad range of life sciences organizations, including biopharma companies, CROs, and sponsors, providing compliant workflows, data management, and insights software for both GxP and non-GxP environments. Notably, 15 of the top 20 biopharma companies by market cap are IDBS customers of 10 or more years.

IDBS is part of Danaher Corporation, a global life sciences and diagnostics innovator, which connects IDBS to a broad ecosystem of expertise, technologies, and capabilities. Powered by the Danaher Business System and a culture of continuous improvement, IDBS partners closely with customers to solve complex challenges with greater speed and certainty.

Core Platform: IDBS Polar

• IDBS Polar is a cloud-based, next-generation scientific data and workflow platform, first released in 2020 as an evolution of the earlier on-premise E-WorkBook ELN.
• IDBS Polar Control — launched in 2025 — provides parameter control and process lifecycle management, functioning as a "recipe book" for drug development to enhance process control, accelerate understanding, and drive data-driven optimization, including support for tech transfer.
• IDBS Polar Insight — released in 2022 — adds AI/ML and advanced analytical and data management capabilities to the platform.
• Polar supports instrument integration, bioreactor comparison reports, multivariate analysis (MVA), and Design of Experiments (DoE).

Key Workflow Solutions and Modules

• Research: Digitalizes research projects by unifying and contextualizing data across experiments, capturing experimental information, storing any type and format of data, and ensuring all data is searchable — giving research teams complete visibility into their processes.
• Bioanalysis: Provides digital solutions for workflows and integrations to enable CROs, sponsors, and biopharma organizations to improve quality and reproducibility, reduce study cycle times, accelerate time-to-market, and reduce regulatory burden within a fully compliant framework.
• Development: Digitalizes the drug development lifecycle by capturing scientific data at execution, automating business and laboratory processes, and integrating and contextualizing experiment, product, and process data to accelerate process development, process characterization, scale-up, and tech transfer.
• Cell Line Development (CLD): Delivers tools for CLD teams to capture product and process data, integrate process and analytical data, establish and characterize stable cell lines, trace cell line genealogy, and generate trustworthy cell line history reports.
• Process Development: Supports digital workflows for process development activities throughout the drug development lifecycle.
• PIMS (Process Information Management System): Added in 2021 via the Skyland Analytics acquisition, extending IDBS capabilities into manufacturing process information management.

Compliance, Quality, and Security

• IDBS products and services are proven to ensure data integrity and comply with applicable GxP regulations, backed by over 35 years of experience working with regulated pharmaceutical customers.
• The company holds ISO, SOC, and ESG certifications and has been awarded Platinum pharma supplier status by Qualifyze, the world's leading third-party audit provider for healthcare and pharma companies (2025).
• IDBS is top-rated for GxP compliance support and experience, as measured in a market research study comparing IDBS to seven other comparable software vendors used in R&D, preclinical CROs, and process development.
• A comprehensive approach to quality and information security ensures working practices and controls are subject to continuous assurance, supporting transparency and compliance.

Recognition and Market Presence

• Recognized as a Top Life Sciences Informatics Company in Europe by Life Sciences Review.
• Winner of the Best Biologics Digitalisation Award: Data Analytics for Quality Processes at the Asia Pacific Biologics CMO Excellence Awards.
• Named among Top Laboratory Automation Solutions Companies by pharmatechoutlook.com.
• Winner of the Best Bioprocessing Supplier Award: Software at the Asia Pacific Biopharma Excellence Awards (ABEA) 2025.
• Ranked highest in satisfaction and most used scientific lab data platform in a 2025 market research study with 856 respondents across ten comparable platforms.

Company History and Global Presence

• Founded in 1989, IDBS has grown from screening data management software (ActivityBase, 1994) to a comprehensive cloud-based enterprise informatics platform.
• Key milestones include the release of E-WorkBook (2006), the acquisition of Quantrix for financial analysis and scenario modeling (2010), the launch of cloud-based solutions (2017), and the acquisition of Skyland Analytics (2021) to add AI/ML capabilities.
• IDBS supports a Digital Maturity Webinar Series to guide organizations through the steps needed to unlock the full potential of digital solutions.
• Global offices are located in London (UK), Boston (USA), Paris (France), Munich (Germany), Bangalore (India), Seoul (South Korea), and Tokyo (Japan), with channel partner support through ITOCHU Techno-Solutions Corporation (CTC) in Japan.

With a 35-year track record, deep GxP expertise, and a continuously evolving cloud platform, IDBS is a trusted partner for life sciences organizations seeking to accelerate drug development, ensure regulatory compliance, and harness the power of AI/ML and advanced analytics across the full biopharmaceutical lifecycle.